Home India Competition Commission of India CCI approves the proposed combination involving inter-alia s...
Date: 2026-06-16 Category: Press Release State: Union Government Country: India

CCI approves the proposed combination involving inter-alia subscription to certain CCPS and acquisition of certain equity share capital of Romsons Group by Jongsong Investments

Issued by Competition Commission of India · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Summary of CCI Approval: Jongsong Investments and Romsons Group Private Limited** On June 16, 2026, the Competition Commission of India (CCI) announced its approval of a proposed combination involving Jongsong Investments Pte. Ltd. (Acquirer) and Romsons Group Private Limited (Target). **Transaction Overview** The combination consists of internal restructuring within the Target group, the Acquirer's subscription to specific compulsorily convertible preference shares (CCPS), and the acquisition of a portion of the Target’s equity share capital. **Entity Profiles** * **Acquirer (Jongsong Investments Pte. Ltd.):** An investment holding company that operates as an indirect wholly owned subsidiary of the Singapore-based investment firm, Temasek Holdings Private Limited. The Acquirer has no physical presence or business operations in India outside of its investment holdings. Temasek’s global portfolio spans various sectors, including Financial Services, Transportation & Industrials, Telecommunications, Media & Technology, Consumer & Real Estate, and Life Sciences & Agri-Food. * **Target (Romsons Group Private Limited):** A company specializing in the manufacture and sale of medical devices as well as personal care and hygiene products. Its operations serve both the Indian domestic market and international markets via exports. **Additional Information** * **Release ID:** 2273667 * **Location:** PIB Delhi * **Status:** A detailed order from the Commission regarding this approval is pending.

Key Entities Referenced

Competition Commission of India: The statutory regulator that approved the proposed acquisition and internal restructuring involving Romsons Group and Jongsong Investments. Romsons Group Private Limited: The target entity engaged in the manufacture and sale of medical devices and hygiene products, undergoing internal restructuring and a stake sale. Jongsong Investments Pte. Ltd.: The acquiring investment holding company seeking to subscribe to CCPS and acquire equity share capital in the Romsons Group. Temasek Holdings Private Limited: A Singapore-headquartered global investment firm and the ultimate parent company of the acquirer, Jongsong Investments.
Official Source Record View Original Source →
See Full Document Text
Competition Commission of India CCI approves the proposed combination involving inter-alia subscription to certain CCPS and acquisition of certain equity share capital of Romsons Group by Jongsong Investments प्रव तथ: 16 JUN 2026 6:37PM by PIB Delhi The Competition Commission of India (CCI) has approved the proposed combination involving inter-alia subscription to certain CCPS and acquisition of certain equity share capital of Romsons Group Pvt. Ltd. by Jongsong Investments Pte. Ltd. The Proposed Combination entails an internal restructuring by Romsons Group Private Limited (Target) group and subscription to certain compulsorily convertible preference shares and acquisition of certain equity share capital of the Target by Jongsong Investments Pte. Ltd. (Acquirer). The Acquirer is an investment holding company and does not have any business operations other than holding investments or physical presence in India. It is an indirect wholly owned subsidiary of Temasek Holdings Private Limited (Temasek), which is an investment company headquartered in Singapore. Temasek’s global portfolio covers a broad spectrum of industries including Transportation & Industrials; Financial Services; Telecommunications, Media & Technology; Consumer & Real Estate; and Life Sciences & Agri-Food. The Target is engaged in manufacture and/or sale of medical devices and personal care & hygiene products in India and globally, by way of exports. Detailed order of the Commission will follow. **** NB/ONP (रलीज़ आईडी: 2273667) आगंतुक पटल : 149 इस वज्ञ को इन भाषाओ ंम पढ़: Urdu , ही , Tamil

Continue your research